Regulatory Approval

Relay Therapeutics' experimental drug, zovegalisib, offers new hope for a common and hard-to-treat form of advanced breast cancer with a promising safety profile.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

Promega's new diagnostic for KEYTRUDA gains NMPA approval, opening doors for targeted solid tumor therapy amid China's growing precision medicine market.

McCain Foods launches its third 'Farm of the Future' in the UK, showcasing major strides in regenerative agriculture and setting ambitious 2030 climate goals.

A landmark Medicare decision doubles payment for contrast-enhanced ultrasound, positioning the safer, cheaper alternative to challenge CT and MRI dominance.

With a $201M war chest, Muzero Acquisition Corp joins a revitalized SPAC market, targeting the next big tech-enabled company in a high-stakes search.

TeraWulf is acquiring old industrial sites in KY and MD, adding massive power capacity for the AI boom while aiming to stabilize regional energy grids.

After a brutal cold snap, Michiganders face huge energy bills. Consumers Energy is offering aid, but it highlights a growing crisis of affordability.

A $6.8M judgment against a VA claims company reveals a battle for ethics, spurring laws to protect veterans from deceptive and costly practices.

Amid rising drug price scrutiny, Red Nucleus acquires an AI-powered consultancy to revolutionize how biopharma proves the value of new medicines.

Japanese insurer Meiji Yasuda finalizes its acquisition of a top U.S. life and pension player, signaling a major strategic push into the American market.

MAPS and Columbia University launch a landmark study into MDMA-assisted couples therapy, seeking to turn decades of underground practice into a safe future.

A looming federal tax credit deadline threatens solar projects. NuGen Capital's strategic investment aims to save distressed assets and stabilize the grid.

The safety giant is launching its 35-2X Series gas ignition controls, targeting Europe and APAC's booming HVAC, ag, and cooking equipment markets.

Ensem Therapeutics expands its global trial for ETX-636, a next-gen cancer drug designed to avoid common toxicities, into China's vast patient market.

Commvault's new solution addresses rising global demand for data control, helping organizations navigate complex regulations without sacrificing cyber resilience.

Following a federal probe into a Waymo robotaxi hitting a child, the Teamsters union calls for an indefinite ban, escalating the battle over AV safety and jobs.

A landmark six-month test of an electric aircraft in Norway is complete, providing a crucial blueprint for the future of zero-emission global air travel.

A state-funded grant unites UCLA and industry to create a scientific benchmark for cannabis flavors, aiming to enhance public safety and regulatory clarity.

A life-changing treatment for a rare kidney disease is now easily accessible in France, ending a long wait for patients and bolstering a French pharma firm.